SPEAKER_01 0:00

By the year 2035, uh the global medical community projected that we would hit twelve million people living with Parkinson's disease.

SPEAKER_00 0:07

Right.

SPEAKER_01 0:08

But you know, we didn't hit that number in twenty thirty-five. I mean, we hit it today.

SPEAKER_00 0:11

Yeah, it's it's wild. We arrived at that staggering statistic a full decade early.

SPEAKER_01 0:17

Right. Which makes Parkinson's the the absolute fastest growing neurological condition on the planet right now.

SPEAKER_00 0:23

It is. And it's outpacing Alzheimer's, which I think um surprises a lot of people.

SPEAKER_01 0:28

Aaron Powell Oh, absolutely. It's completely upending how healthcare systems prepare for the future.

SPEAKER_00 0:33

Aaron Powell Yeah. The acceleration is is deeply concerning. Yeah. And it just means that the old textbook approaches, you know, they simply don't cut it anymore. Right. We are dealing with this massive demographic shift.

SPEAKER_01 0:43

Aaron Powell Yeah, and patients and their families are just navigating an absolute avalanche of information.

SPEAKER_00 0:48

Okay, yeah.

SPEAKER_01 0:48

Some of it is groundbreaking, but a lot of it is outdated, and some of it is just dangerously false. Okay, so let's unpack this. Our mission for this deep dive is to act as your expert guides. We've spent time, you know, really analyzing the latest methodologies and consensus statements from the world's leading neurologists. Trevor Burrus, Jr.

SPEAKER_00 1:07

Right. Figures like Dr. Bess Bloom, Dr. Michael O'Koon, uh Dr. Ray Traduri, and Dr. Fabrizio Stocci.

unknown 1:14

Yeah.

SPEAKER_01 1:14

We are looking strictly at the facts here. We are going to map out exactly what works, what doesn't, and how a fundamentally different whole person approach is rewriting the rules of the disease.

SPEAKER_00 1:26

Aaron Powell And I think the foundation of that rewrite really starts with Dr. Michael O'Koon.

SPEAKER_01 1:30

Oh, yeah, definitely.

SPEAKER_00 1:31

He recognized that for decades neurology was just purely symptom-driven.

SPEAKER_01 1:35

Aaron Powell Like completely.

SPEAKER_00 1:36

Right. A doctor would look at a tremor, they'd prescribe a pill to stop the tremor and just send the patient home. The disease itself was the center of attention. Trevor Burrus, Jr.

SPEAKER_01 1:44

Which is so backward.

SPEAKER_00 1:45

Yeah. So Dr. Okun basically stripped that down and built what he calls the Parkinson's universe model. And it completely reorganizes the hierarchy of care.

SPEAKER_01 1:54

Aaron Ross Powell I find this model so brilliant because it it shifts the gravity of the entire clinical experience. Like in Okun's universe, the patient is the sun. They sit at the absolute gravitational center of everything. And then Mercury, you know, the closest planet in orbit, that represents the caregiver.

SPEAKER_00 2:09

Aaron Powell Yeah, relying on just constant, honest communication.

SPEAKER_01 2:12

Exactly. And then the other orbiting planets, those are the multidisciplinary care team.

SPEAKER_00 2:16

And then you have Pluto.

SPEAKER_01 2:17

Right. Pluto. Orbiting way out there on the icy edges.

SPEAKER_00 2:20

Yeah.

SPEAKER_01 2:21

But it's still exerting a pull.

SPEAKER_00 2:22

Yeah. And that represents social stigma, which is huge.

SPEAKER_01 2:26

Oh wow. Yeah. That is huge.

SPEAKER_00 2:28

Aaron Ross Powell But a critical part of Okin's model that I think often gets overlooked in the clinic are the asteroid fields.

SPEAKER_01 2:34

Oh, right. The asteroids.

SPEAKER_00 2:35

Yeah. These are the systemic obstacles that are constantly threatening to crash into the system. So insurance battles, lack of access to specialists, and just crippling financial costs.

SPEAKER_01 2:47

Aaron Ross Powell Right. So if a neurologist only focuses on prescribing a medication, but they ignore the asteroid field of whether the patient can actually afford it, the whole orbit destabilizes.

SPEAKER_00 2:58

Well, exactly. The treatment fails not because the science was bad, but because the delivery system was just ignored.

SPEAKER_01 3:03

Aaron Powell Yeah. Which feeds directly into Alexander Reed's philosophy.

SPEAKER_00 3:07

Aaron Powell Oh, from the European Parkinson Therapy Center. Right.

SPEAKER_01 3:10

He's the founder there. And he was diagnosed at a young age, faced that exact same clinical apathy, and decided to just completely change the narrative.

SPEAKER_00 3:18

Aaron Powell Right. He argues that we have to stop viewing people with Parkinson's as sick in the traditional terminal sense. Trevor Burrus, Jr.

SPEAKER_01 3:25

Yeah, because from a biological standpoint, every single human being naturally loses dopamine as they age.

SPEAKER_00 3:33

Exactly. People with Parkinson's are simply losing it at an accelerated rate.

SPEAKER_01 3:37

Right. And that framing, it completely alters the psychological burden.

SPEAKER_00 3:42

It does. You aren't defined by sickness, you are managing a physiological deficit. Yeah. And that deficit looks different for everyone.

SPEAKER_01 3:50

Oh, totally.

SPEAKER_00 3:50

I mean, The Lancet recently published an incredibly stark insight on this. Clinically speaking, there isn't just one Parkinson's disease.

SPEAKER_01 3:57

Wait, really?

SPEAKER_00 3:58

Yeah, because the progression, the specific combinations of motor and non-motor symptoms, and even the medication responses, they vary so wildly. So there are essentially seven million or even up to 12 million different Parkinson's diseases in the world today.

SPEAKER_01 4:15

Aaron Powell Because no two people experience the progression the exact same way.

SPEAKER_00 4:19

Exactly.

SPEAKER_01 4:20

You know, it reminds me of an analogy. It's like the old model of treating Parkinson's was like a mechanic fixing a broken car engine.

SPEAKER_00 4:27

Okay. Yeah.

SPEAKER_01 4:28

Like they're just focusing purely on the mechanical symptom, the broken part.

SPEAKER_00 4:31

Right, the tremor.

SPEAKER_01 4:32

Right. Whereas this new holistic model, it's more like a master gardener tending to a whole ecosystem.

SPEAKER_00 4:37

Oh, I love that.

SPEAKER_01 4:38

You know, you have to adjust the soil, the water, the sunlight specific to that exact plant to get it to thrive.

SPEAKER_00 4:45

That's a perfect way to look at it. Because if we have millions of variations of the condition, a one-size-fits-all treatment plan is clinically useless.

SPEAKER_01 4:53

Yeah, completely useless. We need to stabilize this highly individualized universe with a bedrock of hard science. Right. And that brings us to what Dr. Baez-Bloem categorizes as the white zone of evidence.

SPEAKER_00 5:06

Yes, the white zone. These are the interventions that have passed the absolute most rigorous, undisputed clinical trials.

SPEAKER_01 5:12

Aaron Powell Okay, so let's talk about what's in there. The heavyweight champion of the white zone is still levadobo, right?

SPEAKER_00 5:19

It is. It remains the gold standard. It's a dopamine precursor that crosses the blood-brain barrier. Okay. And it converts directly into dopamine to basically replace what the brain has lost. Right. But we have to look at how the body actually processes this drug because the mechanics explain why treating Parkinson's is so, so complicated.

SPEAKER_01 5:39

Aaron Powell Yeah, because lividopa is actually absorbed in the small intestine, right? Not the stomach.

SPEAKER_00 5:43

Exactly. And Parkinson's affects the autonomic nervous system, which can severely slow down gastric emptying.

SPEAKER_01 5:49

Oh, right. So the stomach muscles just become sluggish.

SPEAKER_00 5:53

Yeah, exactly the problem. So a patient takes their lividopa, but instead of moving into the small intestine, the pill just sits in the stomach. Wow. Yeah. The brain is starving for dopamine, the patient starts freezing up, but the medication is literally trapped in transit.

SPEAKER_01 6:08

Aaron Powell Sounds so frustrating. It creates this vicious cycle of unpredictable motor fluctuations.

SPEAKER_00 6:14

It does. And it is also exactly why neurologists stress the extreme danger of stopping lividopa abruptly. Right. Sudden withdrawal throws the brain's chemical balance into a life-threatening crisis. You cannot just stop taking it.

SPEAKER_01 6:27

Aaron Powell Okay. So for those advanced stages where the oral medication is getting trapped or you know creating those massive peaks and valleys, what else is in the white zone?

SPEAKER_00 6:36

Aaron Powell Well, there's the enteral of a dopapump.

SPEAKER_01 6:38

Oh, yeah.

SPEAKER_00 6:39

It bypasses the stomach entirely. It delivers a continuous gel form of the medication straight into the intestine.

SPEAKER_01 6:45

Okay, so it maintains a perfectly steady state in the bloodstream.

SPEAKER_00 6:48

Exactly.

SPEAKER_01 6:49

But alongside the chemistry, we have the surgical interventions too, right? Specifically deep brain stimulation or DBS.

SPEAKER_00 6:55

Yeah. Let's unpack the mechanics of DBS. It specifically targets the STN or the subthalamic nucleus. Okay. The STN is this tiny lens-shaped cluster of neurons acting as a major relay station in the brain's motor circuit. Right. In Parkinson's, because of the dopamine loss, this relay station becomes hyperactive. It starts firing off chaotic, faulty electrical signals.

SPEAKER_01 7:17

And that manifests outwardly as the tremors and the rigidity.

SPEAKER_00 7:21

Exactly. So the neurosurgeon implants tiny electrodes directly into that STN relay station.

SPEAKER_01 7:27

Okay, so those electrodes act like a case maker for the brain.

SPEAKER_00 7:30

Yes.

SPEAKER_01 7:31

They emit continuous electrical pulses that effectively override those chaotic signals.

SPEAKER_00 7:37

That's right. It doesn't cure the underlying disease and it doesn't create new dopamine, but it bypasses the symptom pathway. Wow. And a newer intervention in this space is focused ultrasound, or FUS.

SPEAKER_01 7:49

Oh, what's that?

SPEAKER_00 7:50

Instead of open brain surgery, FUS uses intersecting sound waves to temporarily open the blood-brain barrier for targeted therapies.

SPEAKER_01 7:58

Oh wow, really?

SPEAKER_00 7:59

Yeah, or to selectively ablate malfunctioning tissue. The technology in the white zone is just staggering.

SPEAKER_01 8:05

It really is. But I do want to push back on the timeline for these interventions, though. Okay. Because reading through the Canadian Every Victory Counts Manual, there is a very prevalent mindset among patients.

SPEAKER_00 8:15

Yeah.

SPEAKER_01 8:15

People often say they want to wait to start medication or hold off on DBS until they quote unquote get bad enough. Right. The fear is that these treatments only have a shelf life of a few years. So they want it to save their ammunition for the later stages. Is that actually a factual strategic way to approach this?

SPEAKER_00 8:33

No. It is a pervasive fear, but medically, waiting is a fundamentally flawed strategy.

SPEAKER_01 8:38

Interesting.

SPEAKER_00 8:39

Clinical consensus across the board is that the goal of Parkinson's treatment is quality of life today. Why wait when you are struggling right now? Right. One clinician in the manual challenges this beautifully by asking their patients, bad enough for what? I can see you struggling to walk into my office. How bad do you have to get before you give yourself permission to feel better?

SPEAKER_01 9:00

Wow. That completely reframes the decision.

SPEAKER_00 9:03

It does.

SPEAKER_01 9:04

Denying yourself mobility and independence today doesn't put the disease on pause. It just guarantees that you suffer unnecessarily in the present.

SPEAKER_00 9:12

Exactly. The white zone therapies are tools designed to maximize your function right now. Right. But pills and pacemakers merely create a therapeutic window. The question becomes what do you do with that window? And this shifts us into what Dr. Blum calls the shades of gray. These are lifestyle interventions that are rapidly building enough clinical data to move into the white zone.

SPEAKER_01 9:33

Right. And the European Parkinson Therapy Center's region protocol is a perfect example of this.

SPEAKER_00 9:38

Oh, absolutely.

SPEAKER_01 9:39

They developed this four-pillar approach, treating medicines, physical activity, lifestyle, and psychological well-being with equal clinical weight.

SPEAKER_00 9:48

Yeah.

SPEAKER_01 9:48

And they are seeing up to a 60% motor recovery rate with this.

SPEAKER_00 9:52

It's incredible. And that happens because of synergy. Right. The medicines create the dopamine window, the psychological support lowers stress hormones that exacerbate tremors, and the lifestyle adjustments lock in the routine.

SPEAKER_01 10:04

Yeah. But the physical activity pillar is the real powerhouse here, isn't it?

SPEAKER_00 10:08

Oh, absolutely. Exercise is quite literally medicine for the brain. It physically alters neuroplasticity.

SPEAKER_01 10:15

Which is amazing to think about.

SPEAKER_00 10:16

Yeah. And we have a fascinating proof of concept for this from Dr. J. Alberts.

SPEAKER_01 10:20

Oh, the tandem bike story.

SPEAKER_00 10:22

Yes. Back in 2003, he was riding a tandem bicycle across Iowa with a friend who had Parkinson's. Okay. Because they were on a tandem bike, their pedals were locked together. Dr. Alberts naturally pedaled at a higher cadence, which physically forced his friend's legs to move much faster than they could have on a solo bike.

SPEAKER_01 10:40

Wow. So he's basically dragging them along at this high speed.

SPEAKER_00 10:43

Essentially, yeah. And after that ride, the improvement in his friend's motor function was undeniable.

SPEAKER_01 10:49

That's wild.

SPEAKER_00 10:50

The tremors were suppressed, the coordination improved. It led to these huge clinical trials that proved high-intensity, forced aerobic exercise drastically enhances motor and cognitive function.

SPEAKER_01 11:02

Aaron Powell Because when you force the body to perform at a higher aerobic threshold, it triggers the release of BDNF, right? Brain-derived neurotrophic factor.

SPEAKER_00 11:10

Aaron Powell Exactly. It acts like fertilizer for the brain. It promotes the survival of existing neurons and encourages new synaptic connections. Right. The data on physical therapy is so strong now that an international delphi consensus, which is a formal agreement among leading medical experts, strongly advises coupling surgical interventions directly with exercise.

SPEAKER_01 11:31

Okay, so like if a patient undergoes STN DBS surgery, they must immediately pair it with intense targeted physical therapy.

SPEAKER_00 11:39

Yes. The surgery addresses the tremors, but the physical therapy is required to retrain postural stability and gait.

SPEAKER_01 11:46

I see. But I know high-intensity force aerobic exercise sounds incredibly daunting to someone who's just struggling with basic balance.

SPEAKER_00 11:54

Oh, for sure.

SPEAKER_01 11:55

And that is where Dr. Bloom's concept of exercise snacks is a total game changer.

SPEAKER_00 12:00

Yes, I love that concept.

SPEAKER_01 12:01

It's essentially microdosing physical therapy, so it doesn't feel overwhelming. You don't need a grueling hour at the gym.

SPEAKER_00 12:07

Right.

SPEAKER_01 12:07

You take two minutes to briskly walk up and down the stairs, but you do it 15 times throughout the day.

SPEAKER_00 12:12

Yeah, you accumulate the aerobic benefit and the BDNF release without hitting a wall of exhaustion.

SPEAKER_01 12:17

Exactly. And what's fascinating here is that the goal of modern research is to build firm evidence to move these gray therapies into the white zone.

SPEAKER_00 12:25

Right. So doctors can prescribe them confidently or discard them to save patients money. And this extends heavily into nutrition as well.

SPEAKER_01 12:33

Oh, yeah, the mine and Mediterranean diets.

SPEAKER_00 12:35

Exactly. They offer immense neuroprotective benefits. High fiber is crucial. But we also have to look at specific metabolic interactions. For instance, the long-term metabolism of lavodopa utilizes an enzyme pathway that actively strips the body of methyl groups. Uh oh. Yeah, which can severely deplete vitamin B12. And that depletion leads to elevated homocysteine levels, driving neuropathy, and cognitive decline.

SPEAKER_01 13:02

Oh well. So B12 supplementation isn't just a wellness trend here. It's a biochemical necessity for patients on high doses of lavodopa.

SPEAKER_00 13:10

Exactly.

SPEAKER_01 13:10

We also see the grade of white transition with acute stress management.

SPEAKER_00 13:13

Yes, definitely.

SPEAKER_01 13:14

The manual notes that a patient can be perfectly controlled all morning, but if the doorbell rings and unexpected guests arrive, the social anxiety triggers a massive sympathetic nervous system spike. Yeah, and suddenly their hand is shaking uncontrollably. But for those specific temporary stress-induced tremors, the beta blocker propranolol is proven to be highly effective.

SPEAKER_00 13:37

Yeah, it blunts the adrenaline response. But to be clear, it acts as a situational tool, not a daily Parkinson's drug.

SPEAKER_01 13:43

Right, right. But that desperation for immediate relief when symptoms fluctuate, I mean, that is exactly what makes patients vulnerable.

SPEAKER_00 13:51

Oh, totally.

SPEAKER_01 13:52

When the evidence-based regimens feel overwhelming, it's tempting to look for a quick fix. Which brings us to the danger of the black zone.

SPEAKER_00 14:01

Yes, the black zone. Dr. Bloom uses this concept for therapies that lack any credible scientific evidence. Okay. He points to the phenomenon of swimming with dolphins. Oh gosh. Right? It sounds wonderful, and being in the water with a beautiful animal might absolutely lower your cortisol levels and improve your mood. Sure. But there is zero clinical data suggesting it alters the pathology of Parkinson's.

SPEAKER_01 14:25

Right. Or people spending thousands of dollars on generic off-the-shelf probiotics hoping to cure their gut motility issues.

SPEAKER_00 14:32

Exactly. While gut health is undeniably central to Parkinson's, throwing random, unvetted probiotic strains at the problem lacked rigorous evidence. And it can drain a family's finances. The goal of categorizing these zones is to empower patients. If it's in the white zone, demand it.

SPEAKER_01 14:47

Demand it, yeah.

SPEAKER_00 14:48

If it's in the gray zone, participate in the research. If it's in the black zone, save your money and your energy. Trevor Burrus, Jr.

SPEAKER_01 14:54

And you need that energy to fight the hidden battles of this disease.

SPEAKER_00 14:58

Oh, absolutely.

SPEAKER_01 14:59

Because we naturally fixate on the visible symptoms, right? The tremors, the rigidity, the slow movements. But Parkinson's is fundamentally a multisystem disorder.

SPEAKER_00 15:10

It is.

SPEAKER_01 15:10

And the non-motor symptoms are often far more debilitating.

SPEAKER_00 15:13

Aaron Powell, yeah. Alexander Reed frequently points out that the psychological and cognitive changes terrify patients far more than the physical ones.

SPEAKER_01 15:21

I can imagine.

SPEAKER_00 15:22

Specifically the onset of severe apathy.

SPEAKER_01 15:25

And this is a major aha moment for families to understand. Because apathy in Parkinson's is not a psychological reaction to being chronically ill.

SPEAKER_00 15:33

Right.

SPEAKER_01 15:33

It isn't a character flaw. And it doesn't mean the person is just bummed out or giving up.

SPEAKER_00 15:38

No, not at all.

SPEAKER_01 15:39

It is chemical apathy. The dopamine deficiency literally starves the brain's reward and motivation centers.

SPEAKER_00 15:45

Exactly.

SPEAKER_01 15:46

The patient physically loses the chemical required to want to engage in life. And understanding that mechanism completely changes how a caregiver responds to their loved one's behavior.

SPEAKER_00 15:55

It really does. It removes the blame.

SPEAKER_01 15:57

Yeah.

SPEAKER_00 15:58

We also see massive disruptions in the autonomic nervous system. A prime example is NOH or neurogenic orthostatic hypotension.

SPEAKER_01 16:06

Oh, the blood pressure dropped.

SPEAKER_00 16:08

Right. Under normal conditions, when you stand up, your nervous system instantly constricts your blood vessels to pump blood against gravity up to your brain.

SPEAKER_01 16:17

Okay.

SPEAKER_00 16:17

In Parkinson's, that autonomic signal fails. The blood pressure tanks, resulting in severe dizziness or dangerous falls simply from standing up from a chair.

SPEAKER_01 16:27

Wow. And sleep architectures also destroy it, right?

SPEAKER_00 16:30

Yeah, completely.

SPEAKER_01 16:31

The circadian rhythm fractures. But here again, understanding the why leads to targeted treatments. Exactly. Because dopamine is heavily involved in regulating our sleep wake cycles, specifically through pathways originating in the retina of the eye. Right. Parkinson's causes a deficiency in retinal dopamine. So to combat this, targeted blue light therapy is showing immense promise.

SPEAKER_00 16:54

Yeah. Exposing the eyes to specific wavelengths of blue light stimulates photodeceptors that bypass the normal visual system.

SPEAKER_01 17:00

Right.

SPEAKER_00 17:01

They talk directly to the brain's master clock to manually reset those dopamine-dependent circadian rhythms.

SPEAKER_01 17:07

It's so fascinating. But tracking all of these invisible underlying mechanisms requires serious vigilance.

SPEAKER_00 17:14

It really does.

SPEAKER_01 17:15

And Dr. Rachuturi champions the use of a dashboard of vitals for non-motor symptoms.

SPEAKER_00 17:20

Yes.

SPEAKER_01 17:21

Just as a mechanic plugs a computer into your car to read the invisible sensor data, a neurologist needs a standardized checklist to evaluate sleep, apathy, and blood pressure at every single visit.

SPEAKER_00 17:31

Exactly. You cannot treat what you do not track.

SPEAKER_01 17:34

Right. But to manage a dashboard with that many warning lights, I mean a 15-minute visit with a neurologist twice a year is woefully inadequate.

SPEAKER_00 17:42

Completely inadequate. The World Health Organization and the International Consensus Statements are resolute on this point. Patients require a multidisciplinary care team from the exact point of diagnosis.

SPEAKER_01 17:52

Aaron Powell Not just in the late stages.

SPEAKER_00 17:54

Right. You need physical therapists, occupational therapists, speech language pathologists, and psychologists operating cohesively.

SPEAKER_01 18:02

And Italy has modeled an incredible infrastructure for this, haven't they? Yeah. The Amico Parkinson Call Center.

SPEAKER_00 18:08

Yes. It is a dedicated hotline staffed exclusively by expert Parkinson's nurses.

SPEAKER_01 18:14

That is so smart.

SPEAKER_00 18:15

It really is. When a patient experiences a sudden medication failure or severe anxiety spike, they don't have to wait three months for an appointment. Right. They call the center, the nurses intercept the crisis, perform triage, and route the patient to the specific specialist they need immediately. It basically acts as the central nervous system for the multidisciplinary team.

SPEAKER_01 18:35

Okay, so what does this all mean for the person listening right now? The sheer volumes of specialists and mechanisms we just covered is intense. It is a lot. How does a listener, especially a patient or a caregiver, actually manage all these different professionals without it becoming a full-time, overwhelming job?

SPEAKER_00 18:52

Aaron Powell Well, this raises an important question. The medical community refers to the solution as shared decision making, but it really comes down to the patient claiming their agency. The medical team cannot effectively coordinate your care if they do not know what you want your life to look like. Right. The patient must voice specific functional goals rather than just reciting a list of ailments.

SPEAKER_01 19:14

Ah, I see. So instead of sitting on the exam table and saying, My hand shakes, my back hurts, and I'm tired, you reframe the entire objective of the visit.

SPEAKER_00 19:23

Exactly.

SPEAKER_01 19:23

You tell the neurologist, I want to have the fine motor control to play chess with my grandson, or I want the stamina to hike a specific trail with my spouse this summer.

SPEAKER_00 19:32

Yes. Setting a functional goal acts as a focal point for the entire team. Okay. The occupational therapist goes to work on the hand-eye coordination for the chest pieces. The physical therapist designs a regimen for trail balance. Right. And the neurologist meticulously times the levodopid doses so you are fully on during those specific activities.

SPEAKER_01 19:52

That makes so much sense.

SPEAKER_00 19:53

The patient defines the orbit, the medical team just provides the gravity to keep it stable.

SPEAKER_01 19:58

Aaron Powell It all routes right back to Dr. Oaken's model. The patient is the sun.

SPEAKER_00 20:03

Exactly.

SPEAKER_01 20:04

So to kind of bring this all together, whether you are newly diagnosed, adapting to a later stage, or preparing to advocate for a loved one in a medical meeting, you now have the factual playbook of what actually works. Aaron Powell Right.

SPEAKER_00 20:17

Conquering this condition requires a fiercely active, integrated approach. You leverage the white zone evidence, the levadopa, and the surgical interventions. You combine it with robust neuroplasticity-altering exercise like tandem biking. Right. You track the invisible symptoms and you build a multidisciplinary team from day one. That is the architecture of self-efficacy.

SPEAKER_01 20:42

You are totally empowered to demand whole person care. You focus relentlessly on the facts and you control what you can control.

SPEAKER_00 20:48

Absolutely.

SPEAKER_01 20:49

But you know, looking at the broader scope of our research today, there is a lingering thought that feels impossible to ignore.

SPEAKER_00 20:55

Oh.

SPEAKER_01 20:56

We have spent this entire deep dive mapping out how to successfully treat the internal environment of the patient. You know, the brain chemistry, the gut motility, the neuroplasticity.

SPEAKER_00 21:05

Right.

SPEAKER_01 21:05

But we open this conversation with the reality that Parkinson's cases are skyrocketing globally.

SPEAKER_00 21:11

Yeah, we hit 12 million cases a decade ahead of schedule.

SPEAKER_01 21:15

Right. And the epidemiological data links this unprecedented explosion heavily to environmental factors.

SPEAKER_00 21:22

Right. Chronic exposure to agricultural pesticides, industrial solvents, airborne toxins.

SPEAKER_01 21:27

Exactly. We are designing miraculous surgical interventions and complex drug delivery systems to manage the internal devastation of the disease. But if we know the environmental catalysts driving these numbers, when will society take the same rigorous scientific approach to treating our external environment?

SPEAKER_00 21:45

Wow, yeah.

SPEAKER_01 21:46

When do we stop just managing the symptoms of a poisoned population and start cleaning up the world to prevent the disease before it ever takes hold?